Use of the Cutaneous Lupus Disease Area and Severity Index as an outcome measure in clinical trials: a descriptive study.
Saved in:
| Title: | Use of the Cutaneous Lupus Disease Area and Severity Index as an outcome measure in clinical trials: a descriptive study. |
|---|---|
| Authors: | Mack E; Deparment of Dermatology, Belfast Health and Social Care Trust, Belfast, UK., Exton LS; Willan House, British Association of Dermatologists, London, UK., Mohd Mustapa MF; Willan House, British Association of Dermatologists, London, UK., McCourt C; Deparment of Dermatology, Belfast Health and Social Care Trust, Belfast, UK., O'Kane D; Deparment of Dermatology, Belfast Health and Social Care Trust, Belfast, UK. |
| Source: | Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Jan; Vol. 46 (1), pp. 147-152. Date of Electronic Publication: 2020 Oct 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2230 (Electronic) Linking ISSN: 03076938 NLM ISO Abbreviation: Clin Exp Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2230 |
|---|---|
| DOI: | 10.1111/ced.14420 |
